| 000 | 01988cam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030217.0 | ||
| 008 | 100331s2009 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2009.Ra.D | ||
| 100 | 0 | _aRania Abdalla Hussein Abouelnour | |
| 245 | 1 | 0 |
_aDendritic celle vaccine for the treatment of chronic myeloid leukemia / _cRania Abdalla Hussein Abouelnour ; Supervised Mervat Mohamed Saad Elansary , Mervat Mohammed Wagih Mattar , Shereen Mahmoud Kamel Shawky |
| 246 | 1 | 5 | _aمصل من الخلايا الفرعية لعلاج اللوكيميا الميلودية المزمنة |
| 260 |
_aCairo : _bRania Abdalla Hussein Abouelnour , _c2009 |
||
| 300 |
_a187P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aDendritic celle (DCs) are peripheral blood and bone marrow derived antigen - presenting cells responsible for the initiation of immune responses . Because dendritic cells are clinically well tolerated it makes them interesting candidates for anti-tumor or anti - leukemic strategies . The aim of this study was to generate a dendritic cell vaccine (DC vaccine) experessing leukemia antigens by differentiating dendritic celle from myeloid blasts of chronic myeloid leukemia patients to boost their immune system and improve their clinical outcome | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAdjuvant therapy | |
| 653 | 4 | _aChronic myeloid leukemia | |
| 653 | 4 | _aDendritic celle | |
| 700 | 0 |
_aMervat Mohamed Saad Elansary , _eSupervisor |
|
| 700 | 0 |
_aMervat Mohammed Wagih Mattar , _eSupervisor |
|
| 700 | 0 |
_aShereen Mahmoud Kamel Shawky , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c29917 _d29917 |
||